Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Gilead Sciences | INDUSTRY |
Not provided
Not provided
Not provided
The target population for this project will be men-who-have-sex-with-men (MSM) at high risk of HIV acquisition
225 high risk MSM will be interviewed to understand the knowledge and acceptability of pre-exposure prophylaxis (PrEP) in this population in Puerto Rico. A 187 item questionnaire will administered which will evaluate socio-demographic information, sexual conducts, PrEP knowledge and PrEP acceptability.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Part A - high risk MSM | Part A will consist of a descriptive analysis of the acceptability and knowledge on the topic of PrEP of the individuals that undergo routine HIV testing and counseling in study facilities or through outreach activities. Part A will be focused only on high risk MSM. For this part of the study, 225 high risk will be interviewed to understand the knowledge and acceptability of PrEP in this population in Puerto Rico. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| PrEP knowledge and acceptability questionnaire | Behavioral | This questionnaire consists of 187 items and evaluates socio-demographic variables, sex conducts, PrEP knowledge and PrEP acceptability. |
| Measure | Description | Time Frame |
|---|---|---|
| PrEP acceptability using a PrEP knowledge and acceptability questionnaire. | Measure the degree of acceptance of PrEP in the study subjects | One visit |
| PrEP knowledge using a PrEP knowledge and acceptability questionnaire. | Measure the level of education of the study subjects in the topic of PrEP using a questionnaire. | One visit |
Not provided
Not provided
INCLUSION CRITERIA;
Study subjects who meet the following inclusion criteria will be considered for enrollment for Part A:
age 21 years or older
understand and sign the informed consent form and willing to participate in the study
male or transgender female
has one of the following risk factors:
PART A - EXCLUSION CRITERIA:
Subjects with any of the following will not be considered for enrollment in Part A:
Male-to-female transgender subjects are eligible for enrollment
Not provided
225 high risk men who have sex with men, HIV- subjects, 21 years or older , will be enrolled in Part A
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Vivian Tamayo-Agrait, MD | 787-753-9443 | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Puerto Rico Community Network for Clinical Research on AIDS (PR-CoNCRA) | San Juan | PR | 00928 | Puerto Rico |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000163 | Acquired Immunodeficiency Syndrome |
| ID | Term |
|---|---|
| D015658 | HIV Infections |
| D000086982 | Blood-Borne Infections |
| D003141 | Communicable Diseases |
| D007239 | Infections |
Not provided
Not provided
Not provided
Not provided
Not provided
Dried Blood Spots are obtained at 2 time points for participants in part B in order to assess adequate drug levels are retained for bulk shipping for processing at collaborating lab.
| D015229 |
| Sexually Transmitted Diseases, Viral |
| D012749 | Sexually Transmitted Diseases |
| D016180 | Lentivirus Infections |
| D012192 | Retroviridae Infections |
| D012327 | RNA Virus Infections |
| D014777 | Virus Diseases |
| D012897 | Slow Virus Diseases |
| D000091662 | Genital Diseases |
| D000091642 | Urogenital Diseases |
| D007153 | Immunologic Deficiency Syndromes |
| D007154 | Immune System Diseases |